These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8816574)

  • 21. Lessons from randomised direct comparative trials.
    Achiron A; Fredrikson S
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early treatment trials with interferon beta in multiple sclerosis.
    Panitch HS
    Mult Scler; 1995; 1 Suppl 1():S17-21. PubMed ID: 9345392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of progressive forms of multiple sclerosis].
    Edan G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1008-13. PubMed ID: 11787331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulin in MS: promise or failure?
    Fazekas F; Strasser-Fuchs S; Hommes OR
    J Neurol Sci; 2007 Aug; 259(1-2):61-6. PubMed ID: 17449063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
    Edan G; Coustans M
    Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copolymer-1.
    Comi G; Moiola L
    Baillieres Clin Neurol; 1997 Oct; 6(3):495-509. PubMed ID: 10101586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferons in multiple sclerosis: ten years' experience.
    Tourbah A; Lyon-Caen O
    Biochimie; 2007; 89(6-7):899-902. PubMed ID: 17574320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
    Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [[Therapeutic perspectives in multiple sclerosis].
    Lubetzki C; Dubard T; Stankoff B
    Presse Med; 1996 Jun; 25(21):964-6. PubMed ID: 8692772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
    J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and treatment of multiple sclerosis.
    Weinshenker BG; Sibley WA
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):203-11. PubMed ID: 1377973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy in multiple sclerosis, Part 1.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapeutics of multiple sclerosis.
    Durelli L
    Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and therapy of multiple sclerosis].
    Woelk H; Neu I
    Fortschr Med; 1980 Oct; 98(37):1427-30. PubMed ID: 6159291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple sclerosis.
    Keegan BM; Noseworthy JH
    Annu Rev Med; 2002; 53():285-302. PubMed ID: 11818475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term therapeutic trials and multiple sclerosis: a wager?].
    Confavreux C
    Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.